News

Under the agreement, Chromos will engineer cell lines for the expression of a monoclonal antibody for Genitope using the ACE System. The financial details of the agreement were

The researchers have discovered a specific genetic trigger that makes HIV hibernate but awaiting an opportunity to re-emerge. They studied an HIV protein called Tat, which plays a

“With the approval for the treatment of OCD, Cipralex is now approved for the treatment of all major anxiety indications and depression,” said senior vice president Anders Gersel

“Xyrem is a strategic fit for our existing marketing and sales organizations in Canada,” Valeant’s president and CEO, Timothy Tyson said. The agreement calls for Valeant to pay

Of the patients who entered the study, 48% have survived more than six months. To date, 9.7% have demonstrated a clinical response to treatment, including one complete response

Voraxaze is an adjunctive therapy for patients experiencing, or at risk of, toxicity from methotrexate, a widely used anti-cancer agent. The company said that there will now be

Under German law, a domination and profit transfer agreement will enable UCB and Schwarz Pharma to operate as one fully integrated entity. Under the agreement, outside shareholders of

The phase I trial will test the safety and tolerability of single and multiple doses and first results are expected in the fourth quarter of 2007. The trial

Stimuvax is a type of therapeutic vaccine that targets a specific protein found in many tumors, including non-small cell lung cancer. It was developed by Biomira following Cancer